China's total settlement of COVID-19 vaccine expenses from its medical insurance fund nationwide was more than 150 billion yuan ($21.55 billion) in 2021-22, the National Healthcare Security Administration said in a statement on Thursday.

The health insurance fund paid PCR testing expenses worth 4.3 billion yuan in 2022, the administration said.

($1 = 6.9601 Chinese yuan renminbi) (Reporting by Bernard Orr and Ethan Wang Editing by Bernadette Baum)